Cumberland Pharmaceuticals (CPIX) Tops Q2 EPS by 3c, Revenues Miss

August 14, 2019 4:34 PM

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found